Search

Showing total 649 results

Search Constraints

Start Over You searched for: Topic lymphocytes Remove constraint Topic: lymphocytes Journal immunology Remove constraint Journal: immunology Publisher wiley-blackwell Remove constraint Publisher: wiley-blackwell
649 results

Search Results

1. Forthcoming Papers.

2. Forthcoming papers.

3. Forthcoming papers.

4. Forthcoming papers.

5. Forthcoming papers.

6. Forthcoming papers.

7. Forthcoming papers.

8. Immune responses in newly developed short-lived SAM mice II. SELECTIVELY IMPAIRED T-HELPER CELL ACTIVITY IN <em>IN VITRO</em> ANTIBODY RESPONSE.

9. Concanavalin A stimulation of mouse lymphocytes at low concentration II. THE EFFECT OF CONDITIONED MEDIUM FROM PERITONEAL EXUDATE CELLS AND FROM LYMPHOCYTE CULTURES.

10. Special regulatory T-cell review: A rose by any other name: from suppressor T cells to Tregs, approbation to unbridled enthusiasm.

11. The T-cell response to haptenated insulins II. THE ANTIBODY RESPONSE.

12. Control of human T-colony formation by interleukin-2.

13. Thymus-dependent lymphocytes of dengue virus-infected mice spleens mediate suppression through prostaglandin.

14. The role of hepatocyte growth factor and its receptor c-met in interactions between lymphocytes and stromal cells in secondary human lymphoid organs.

15. Establishment of long-term CD154-dependent porcine B-cell cultures.

16. Recirculation of lymphocyte subsets (CD5+ , CD4+ , CD8+ , T19+ and B cells) through fetal lymph nodes.

17. Receptors on lymphocytes for endogenous splenic glycosaminoglycans.

18. Traffic and proliferative responses of recirculating lymphocytes in fetal calves.

19. The absence of delayed-type hypersensitivity reactivity in a syngeneic murine tumour system.

20. Antigen-specific T-cell hyporesponsiveness in MRL congenic mice can be explained by two independent cellular defects.

21. The mechanism of action of the factor in leprosy serum that inhibits the growth of mitogen-stimulated normal human lymphocytes.

22. Effect of interferons on the inhibition of human natural killers by primary monolayer cell cultures.

23. Enhancement of immunity against RSV-induced sarcomas by generation of hapten-reactive helper T lymphocytes.

24. Cellular bases of the production of and response to interleukin-2 in man: role of autologous rosette-forming T-cell subsets defined with monoclonal antibodies.

25. Desensitization <em>in vitro</em>: the role of T-suppressor cells, T-suppressor factor and T-acceptor cells in the inhibition of the passive transfer of contact sensitivity to picryl chloride by exposure to antigen <em>in vitro</em>.

26. Migration inhibition of lymph node lymphocytes as an <em>in vitro</em> assay for cell-mediated immunity in the draining lymph nodes of parenterally immunized mice.

27. Potentiation of natural killer cell activity of human lymphocytes <em>in vitro</em>: the participation of interferon in stimulation with <em>Staphylococcus aureus</em> Cowan I bacteria but not with Protein A.

28. Anti-self receptors V. PROPERTIES OF A MOUSE SERUM FACTOR THAT BLOCKS AUTOROSETTING RECEPTORS ON LYMPHOCYTES.

29. Characterization of immunogenic properties of haptenated liposomal model membranes in mice I. THYMUS INDEPENDENCE OF THE ANTIGEN.

30. Mechanisms of clonal abortion tolerogenesis II. CLONAL BEHAVIOUR OF IMMATURE B CELLS FOLLOWING EXPOSURE TO ANTI-μ CHAIN ANTIBODY.

31. Serological and chromatographic analyses of antigenic structures detected in human brain, thymus and lymph nodes.

32. Lymphokine in the rat I. EVIDENCE THAT LYMPHOTOXIN ACTIVITY INVOLVES BOTH CYTOTOXIC AND STIMULATING FACTORS.

33. Characterization of a T-lymphocyte inhibitor in the serum of tumour-bearing mice.

34. A Proposition on the Distribution of Antibody Affinities, with Implications for the Mechanism of B-cell Activation.

35. Antigen-binding Small Lymphocytes in the Guinea-pig II. THE IMMUNOLOGICAL RESPONSE TO PURIFIED PROTEIN DERIVATIVE OF MAMMALIAN TUBERCULIN.

36. The Role of Macrphages in the Cytotoxic Killing of Tumour Cells in Vitro. I. PRIMARY IMMUNIZATION OF LYMPHOCYTES IN VITRO FOR TARGET CELL KILLING AND THE MECHANISM OF LYMPHOCYTE-MACRPHAGE COOPERATION.

37. Characterization of a monoclonal antibody that recognizes a lymphocyte surface antigen for the cetacean homologue to CD45R.

38. Regulation of T-cell activation in the lung: isolated lung T cells exhibit surface phenotypic characteristics of recent activation including down-modulated T-cell receptors, but are locked into the G0/G1 phase of the cell cycle.

39. Regulation of T-cell activation in the lung: alveolar macrophages induce reversible T-cell anergy <em>in vitro</em> associated with inhibition of interleukin-2 receptor signal transduction.

40. Alloantigen presentation by B cells: analysis of the requirement for B-cell activation.

41. A human T-cell receptor recognizes 'O' - linked sugars from the hinge region of human IgA1 and IgD.

42. Effect of serine/threonine kinase inhibitors on motility of human lymphocytes and U937 cells.

43. The targeting of T-helper cells and tumourcidal macrophages to a B-cell lymphoma using a PPD-monoclonal antibody heteroconjugate.

44. Pattern of lectin binding to murine T lymphocytes.

45. Characterization of lymphocyte receptors for glycosaminoglycans.

46. Non-random migration of CD4+, CD8+ and γδ+ T19+ lymphocytes through peripheral lymph nodes.

47. Mode of Recovery from the Effects of Heterologous Anti-Lymphocyte Serum II. RECOVERY OF THE CELLS INVOLVED IN ANTIBODY PRODUCTION.

48. Antigens in Immunity XVI. A LIGHT AND ELECTRON MICROSCOPE STUDY OF ANTIGEN LOCALIZATION IN THE RAT SPLEEN.

49. Absence of any male-specific antigen recognized by T lymphocytes in X/X<em>Sxr′</em> male mice.

50. Efficient antigen presentation of soluble, but not particulate, antigen in the absence of Wiskott-Aldrich syndrome protein.